Nitric oxide and hormesis.

Biphasic dose response Hormesis Nitric oxide Sperm preservation Tumor promotion Wound healing

Journal

Nitric oxide : biology and chemistry
ISSN: 1089-8611
Titre abrégé: Nitric Oxide
Pays: United States
ID NLM: 9709307

Informations de publication

Date de publication:
01 04 2023
Historique:
received: 08 12 2022
revised: 20 01 2023
accepted: 05 02 2023
pubmed: 11 2 2023
medline: 22 3 2023
entrez: 10 2 2023
Statut: ppublish

Résumé

This present paper provides an assessment of the occurrence of nitric oxide (NO)-induced hormetic-biphasic dose/concentration relationships in biomedical research. A substantial reporting of such NO-induced hormetic effects was identified with particular focus on wound healing, tumor promotion, and sperm biology, including mechanistic assessment and potential for translational applications. Numerous other NO-induced hormetic effects have been reported, but require more development prior to translational applications. The extensive documentation of NO-induced biphasic responses, across numerous organs (e.g., bone, cardiovascular, immune, intestine, and neuronal) and cell types, suggests that NO-induced biological activities are substantially mediated via hormetic processes. These observations are particularly important because broad areas of NO biology are constrained by the quantitative features of the hormetic response. This determines the amplitude and width of the low dose stimulation, affecting numerous biomedical implications, study design features (e.g., number of doses, dose spacing, sample sizes, statistical power), and the potential success of clinical trials.

Identifiants

pubmed: 36764605
pii: S1089-8603(23)00013-7
doi: 10.1016/j.niox.2023.02.001
pii:
doi:

Substances chimiques

Nitric Oxide 31C4KY9ESH

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-17

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest GD is employed by Stantec (ChemRisk), a consulting firm that provides scientific support to the government, corporations, law firms, and various scientific/professional organizations.

Auteurs

Edward J Calabrese (EJ)

Department of Environmental Health Sciences, Morrill I, N344, University of Massachusetts, Amherst, MA, 01003, USA. Electronic address: edwardc@schoolph.umass.edu.

Evgenios Agathokleous (E)

School of Applied Meteorology, Nanjing University of Information Science & Technology, Nanjing, 210044, China. Electronic address: evgenios@nuist.edu.cn.

Gaurav Dhawan (G)

Stantec (ChemRisk), Boston, MA, USA. Electronic address: gaurav.dhawan@stantec.com.

Rachna Kapoor (R)

Saint Francis Hospital and Medical Center, Hartford, CT, USA. Electronic address: dr.rachnakapoor23@gmail.com.

Vikas Dhawan (V)

Department of Surgery, Indian Naval Ship Hospital, Mumbai, India. Electronic address: vikasdhawan76@yahoo.co.in.

Prabhjot Kaur Manes (PK)

Alice Hyde Medical Center, University of Vermont, Malone, NY, USA. Electronic address: Manesprabhjot@yahoo.com.

Vittorio Calabrese (V)

Department of Biomedical and Biotechnological Sciences, School of Medicine University of Catania, Via Santa Sofia 97, Catania, 95123, Italy. Electronic address: calabres@unict.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH